Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity.


Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 20 07 2020
accepted: 20 12 2021
pubmed: 6 1 2022
medline: 11 3 2022
entrez: 5 1 2022
Statut: ppublish

Résumé

A disparity exists in cancer screening rates for the Sexual and Gender Minority (SGM) community. We sought to understand the perceptions and baseline knowledge of cancer screening among SGM community members. Survey administered via social media from June 2018 to October 2018. We asked 31 questions focused on cancer screening, human papillomavirus, emotional distress, and experience with the health care system. Those included were 18 years or older. Cancer screening attitudes and knowledge, as well as perceptions of the health care system were investigated. There were 422 respondents analyzed: 24.6% identified as female, 25.5% as male, 40.1% transgender, and 9.6% as other. 65.4% of the SGM community is not certain what cancer screening to do for themselves. Only 27.3% and 55.7% knew that HPV was a risk factor associated with head and neck cancer and anal cancer, respectively. Half stated their emotional distress prevents them from getting cancer screening. It was identified that process changes in making appointments, comforts during the visit, and formal training for physicians and nurses could increase cancer screening compliance for this community. The transgender population had a trend in more gaps in knowledge of appropriate cancer screening and significant excess emotional distress. Gaps in cancer screening knowledge and emotional and financial distress may be responsible for the disparity of lower cancer screening rates for the SGM population and the transgender population may be most at risk. Appreciating the cancer screening concerns of the SGM population can help shape future clinical and institutional approaches to improve health care delivery.

Identifiants

pubmed: 34984592
doi: 10.1007/s10552-021-01549-4
pii: 10.1007/s10552-021-01549-4
pmc: PMC9076188
mid: NIHMS1794123
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-582

Subventions

Organisme : NCI NIH HHS
ID : P30 CA056036
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA227479
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA056036
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Eur J Endocrinol. 2011 Apr;164(4):635-42
pubmed: 21266549
Int J Transgend. 2018;19(4):417-423
pubmed: 31105477
CA Cancer J Clin. 2015 Sep-Oct;65(5):384-400
pubmed: 26186412
Infect Dis (Auckl). 2019 Jan 28;12:1178633718825077
pubmed: 30728723
Sex Transm Dis. 2019 Oct;46(10):657-662
pubmed: 31517805
Psychiatr Serv. 2020 Feb 1;71(2):151-157
pubmed: 31658897
Transgend Health. 2019 Oct 21;4(1):247-253
pubmed: 31641691
J Sex Med. 2013 Dec;10(12):3129-34
pubmed: 24010586
Am J Public Health. 2010 Mar;100(3):489-95
pubmed: 20075319
Am J Public Health. 2015 Nov;105(11):2356-8
pubmed: 26378843
J Infect Dis. 2014 Feb 1;209(3):369-76
pubmed: 23956439
J Adolesc Health. 2011 Aug;49(2):115-23
pubmed: 21783042
J Gay Lesbian Soc Serv. 2015;27(2):246-261
pubmed: 30996583
Semin Oncol Nurs. 2018 Feb;34(1):37-51
pubmed: 29325817
Pediatrics. 2018 May;141(5):
pubmed: 29661941
LGBT Health. 2019 Aug/Sep;6(6):271-288
pubmed: 31314662
Int J Environ Res Public Health. 2019 Dec 07;16(24):
pubmed: 31817826
Curr Radiol Rep. 2018;6(1):1
pubmed: 29392096
Breast Cancer Res Treat. 2015 Jan;149(1):191-8
pubmed: 25428790
Eur J Radiol. 2010 Jun;74(3):508-13
pubmed: 19359116
Am J Prev Med. 2017 Jul;53(1):e1-e7
pubmed: 28094133
Clin Psychol Rev. 2018 Dec;66:24-38
pubmed: 29627104
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052

Auteurs

Joseph Lombardo (J)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Kevin Ko (K)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Ayako Shimada (A)

Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Nicolas Nelson (N)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Christopher Wright (C)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.

Jerry Chen (J)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Alisha Maity (A)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Marissa L Ruggiero (ML)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Scott Richard (S)

Department of Obstetrics and Gynecology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Dimitrios Papanagnou (D)

Department of Emergency Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Edith Mitchell (E)

Department of Medical Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Amy Leader (A)

Department of Medical Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Nicole L Simone (NL)

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. nicole.simone@jefferson.edu.
Department of Radiation Oncology, Bodine Center for Cancer Treatment, Thomas Jefferson University, 111 S. 11th Street, Philadelphia, PA, 19107, USA. nicole.simone@jefferson.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH